Public health impact of covid-19 vaccines in the US: observational study
- PMID: 35477670
- PMCID: PMC9044401
- DOI: 10.1136/bmj-2021-069317
Public health impact of covid-19 vaccines in the US: observational study
Abstract
Objective: To evaluate the impact of vaccine scale-up on population level covid-19 mortality and incidence in the United States.
Design: Observational study.
Setting: US county level case surveillance and vaccine administration data reported from 14 December 2020 to 18 December 2021.
Participants: Residents of 2558 counties from 48 US states.
Main outcome measures: The primary outcome was county covid-19 mortality rates (deaths/100 000 population/county week). The secondary outcome was incidence of covid-19 (cases/100 000 population/county week). Incidence rate ratios were used to compare rates across vaccination coverage levels. The impact of a 10% improvement in county vaccination coverage (defined as at least one dose of a covid-19 vaccine among adults ≥18 years of age) was estimated During the eras of alpha and delta variant predominance, the impact of very low (0-9%), low (10-39%), medium (40-69%), and high (≥70%) vaccination coverage levels was compared.
Results: In total, 30 643 878 cases of covid-19 and 439 682 deaths associated with covid-19 occurred over 132 791 county weeks. A 10% improvement in vaccination coverage was associated with an 8% (95% confidence interval 8% to 9%) reduction in mortality rates and a 7% (6% to 8%) reduction in incidence. Higher vaccination coverage levels were associated with reduced mortality and incidence rates during the eras of alpha and delta variant predominance.
Conclusions: Higher vaccination coverage was associated with lower rates of population level covid-19 mortality and incidence in the US.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Figures




Comment in
-
The benefits of large scale covid-19 vaccination.BMJ. 2022 Apr 27;377:o867. doi: 10.1136/bmj.o867. BMJ. 2022. PMID: 35477535 No abstract available.
References
-
- World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/.
-
- Centers for Disease Control and Prevention. COVID Data Tracker. https://covid.cdc.gov/covid-data-tracker/#datatracker-home.
-
- Centers for Disease Control and Prevention. 1918 Pandemic (H1N1 virus). 2019. https://www.cdc.gov/flu/pandemic-resources/1918-pandemic-h1n1.html.
-
- Arias E, Tejada-Vera B, Ahmad F, Kochanek KD. Provisional Life Expectancy Estimates for 2020. Vital Statistics Rapid Release. Report No. 015. 2021. https://stacks.cdc.gov/view/cdc/107201.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical